Literature DB >> 17318458

The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population.

Kristin Lester1, Lara Stepleman, Mary Hughes.   

Abstract

Within the multiple sclerosis (MS) population, high prevalence of psychiatric concerns, such as depression and anxiety, has been well documented. The purpose of this study was to examine factors contributing to higher depression and anxiety levels in a sample of 82 patients utilizing MS clinic services. Independent variables included MS physical severity, self-reported cognitive impairment, and perceived illness management, respectively. Results from hierarchical regression analyses indicated that depression was related to the physical severity, self-reported cognitive impairment, and perceived illness management variables. Anxiety was also related to the physical severity and self-reported cognitive impairment variables but not to the perceived illness management ones, suggesting that depression and anxiety symptoms may involve somewhat different processes within MS. The findings of this study support further clinical consideration and additional investigation of these variables in the treatment of anxiety and depression in an MS clinic population.

Entities:  

Mesh:

Year:  2007        PMID: 17318458     DOI: 10.1007/s10865-007-9095-6

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  45 in total

1.  Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.

Authors:  Lydia Chwastiak; Dawn M Ehde; Laura E Gibbons; Mark Sullivan; James D Bowen; George H Kraft
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

2.  Human agency in social cognitive theory.

Authors:  A Bandura
Journal:  Am Psychol       Date:  1989-09

3.  Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning.

Authors:  P A Arnett; C I Higginson; W D Voss; B Wright; W I Bender; J M Wurst; J M Tippin
Journal:  Neuropsychology       Date:  1999-07       Impact factor: 3.295

Review 4.  Multiple sclerosis: side effects of interferon beta therapy and their management.

Authors:  E U Walther; R Hohlfeld
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

5.  Cognition in the early stage of multiple sclerosis.

Authors:  Doreen Schulz; Bruno Kopp; Annett Kunkel; Jürgen H Faiss
Journal:  J Neurol       Date:  2006-04-11       Impact factor: 4.849

6.  Reliable screening for neuropsychological impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Darcy Cox; Laetitia L Thompson; Fred Foley; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  Mult Scler       Date:  2004-12       Impact factor: 6.312

7.  An examination of suicidal intent in patients with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

Review 8.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

9.  Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners.

Authors:  A C J W Janssens; P A van Doorn; J B de Boer; F G A van der Meché; J Passchier; R Q Hintzen
Journal:  Acta Neurol Scand       Date:  2003-12       Impact factor: 3.209

10.  Depression in multiple sclerosis.

Authors:  S L Minden; J Orav; P Reich
Journal:  Gen Hosp Psychiatry       Date:  1987-11       Impact factor: 3.238

View more
  16 in total

1.  Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis.

Authors:  Ruchika Shaurya Prakash; Erin M Snook; Robert W Motl; Arthur F Kramer
Journal:  Brain Res       Date:  2009-06-25       Impact factor: 3.252

2.  Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors:  Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal:  Int J MS Care       Date:  2013

Review 3.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

4.  The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?

Authors:  Lauren B Strober; Allison Binder; Olga M Nikelshpur; Nancy Chiaravalloti; John DeLuca
Journal:  Int J MS Care       Date:  2016 Jul-Aug

Review 5.  Life issues in multiple sclerosis.

Authors:  Rex D Simmons
Journal:  Nat Rev Neurol       Date:  2010-09-21       Impact factor: 42.937

6.  Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life.

Authors:  Mariam Hanna; Lauren Beth Strober
Journal:  Mult Scler Relat Disord       Date:  2020-06-06       Impact factor: 4.339

7.  Short Report: Adherence to Neuropsychological Recommendations in Patients with Multiple Sclerosis.

Authors:  Marnina Stimmel; Shaina Shagalow; Elizabeth K Seng; Jeffrey G Portnoy; Roseann Archetti; Elana Mendelowitz; Jessica Sloan; Jason Botvinick; Lisa Glukhovsky; Frederick W Foley
Journal:  Int J MS Care       Date:  2019 Mar-Apr

8.  Do Flexible Goal Adjustment and Acceptance Help Preserve Quality of Life in Patients with Multiple Sclerosis?

Authors:  Stefaan Van Damme; Annelies De Waegeneer; Jan Debruyne
Journal:  Int J Behav Med       Date:  2016-06

9.  Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Authors:  R S Prakash; E M Snook; J M Lewis; R W Motl; A F Kramer
Journal:  Mult Scler       Date:  2008-08-13       Impact factor: 6.312

10.  The Mental Health Needs of Individuals Living With Multiple Sclerosis: Implications for Occupational Therapy Practice and Research.

Authors:  Arcenio Mesa; Kathryn Hoehn Anderson; Sally Askey-Jones; Richard Gray; Eli Silber
Journal:  Mental Health Spec Interest Sect Q       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.